DnB Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
DnB Asset Management's BBIO Position: Q3 2026 in Review
DnB Asset Management increased its BridgeBio Pharma (BBIO) stake by 49% in Q3 2026, buying an estimated $663K and bringing the position to 26,071 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #591.
DnB Asset Management first reported a position in BBIO in Q3 2025 and has held it in 5 quarters since. 348 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- DnB Asset Management held 26,071 shares of BridgeBio Pharma worth $1.72M as of Q3 2026.
- DnB Asset Management bought 8,516 BridgeBio Pharma shares in Q3 2026, an estimated $663K.
- BridgeBio Pharma made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #591 holding.
- DnB Asset Management first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 5 quarters since.
- 348 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.